Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabetes Care ; 25(4): 718-23, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11919131

RESUMO

OBJECTIVE: There are national mandates to reduce blood pressure (BP) to <130/85 mmHg, LDL cholesterol to <100 mg/dl, and HbA(1c) to <7% and to institute aspirin therapy in patients with diabetes. The objective of this study was to determine the proportion of patients in urban institutions with diabetes and hypertension who meet these treatment goals. RESEARCH DESIGN AND METHODS: Using American Diabetes Association (ADA) guidelines, we evaluated the control of cardiovascular disease (CVD) risk factors in 1,372 patients receiving medical care at two major urban medical centers in Brooklyn and Detroit. Information was extracted from charts of outpatient clinics. RESULTS: Of 1,372 active clinic patients with diabetes and hypertension, 1,247 (90.9%) had type 2 diabetes, and 26.7% met the target blood pressure of 130/85 mmHg. A total of 35.5% met the goal LDL cholesterol level of <100 mg/dl, 26.7% had an HbA(1c) <7%, and 45.6% were on antiplatelet therapy. Only 3.2% of patients met the combined ADA goal for BP, LDL cholesterol, and HbA(1c). CONCLUSIONS: Optimal control of CVD risk factors in adults with diabetes was achieved only in a minority of patients. Results reflect the inherent difficulties in achieving these complex guidelines in our present health care systems.


Assuntos
Doenças Cardiovasculares/epidemiologia , Diabetes Mellitus/fisiopatologia , Hipertensão/fisiopatologia , População Urbana , Adulto , Idoso , Idoso de 80 Anos ou mais , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Pressão Sanguínea , Índice de Massa Corporal , LDL-Colesterol/sangue , Complicações do Diabetes , Diástole , Feminino , Hemoglobinas Glicadas/análise , Humanos , Hipertensão/complicações , Lipoproteínas LDL/sangue , Masculino , Michigan , Pessoa de Meia-Idade , Cidade de Nova Iorque , Inibidores da Agregação Plaquetária/uso terapêutico , Fatores de Risco , Sístole
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...